Skip to main content
TipRanks
Go Ultimate75% OFF

Immunotech Biopharm Ltd (6978) Financial Statements

1 Followers

Immunotech Biopharm Ltd Financial Overview

Immunotech Biopharm Ltd's market cap is currently ¥222.30M. The company's EPS TTM is ¥-0.28; its P/E ratio is -1.08; Immunotech Biopharm Ltd has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 0.00¥ 0.00¥ 0.00¥ 0.00¥ 0.00
Gross Profit¥ -53.87M¥ 0.00¥ 0.00¥ 0.00¥ 0.00
Operating Income¥ -155.80M¥ -198.78M¥ -230.55M¥ -273.93M¥ -344.86M
EBITDA¥ -168.80M¥ -140.03M¥ -177.65M¥ -230.15M¥ -324.33M
Net Income¥ -230.78M¥ -186.91M¥ -334.82M¥ -318.11M¥ -354.22M
Balance Sheet
Cash & Short-Term Investments¥ 154.63M¥ 57.49M¥ 176.97M¥ 79.46M¥ 353.34M
Total Assets¥ 603.20M¥ 564.04M¥ 846.28M¥ 879.44M¥ 1.10B
Total Debt¥ 440.26M¥ 384.56M¥ 784.01M¥ 149.81M¥ 111.05M
Net Debt¥ 385.78M¥ 337.60M¥ 731.85M¥ 91.36M¥ -242.29M
Total Liabilities¥ 569.01M¥ 580.50M¥ 675.39M¥ 373.07M¥ 274.51M
Stockholders' Equity¥ -13.93M¥ -13.30M¥ 173.62M¥ 508.44M¥ 822.26M
Cash Flow
Free Cash Flow¥ -111.92M¥ -153.81M¥ -186.17M¥ -277.49M¥ -435.89M
Operating Cash Flow¥ -97.29M¥ -125.74M¥ -163.63M¥ -180.92M¥ -254.65M
Investing Cash Flow¥ -98.07M¥ 141.10M¥ -116.60M¥ 23.38M¥ -328.21M
Financing Cash Flow¥ 203.20M¥ -20.59M¥ 273.92M¥ -36.06M¥ -11.00M

Currency in CNY

Immunotech Biopharm Ltd Earnings and Revenue History

-600M-400M-200M00 %0.4 %0.8 %1.2 %EarningsProfit Margin20182019202020212022202320242025RevenueEarningsProfit Margin

Immunotech Biopharm Ltd Liabilities to Assets

0500M1B1.5B0 %40 %80 %120 %LiabilitiesLiabilities to Assets20182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

Immunotech Biopharm Ltd Cash Flow

-500M-250M0250M500M750M1B1.3B20182019202020212022202320242025OperatingInvestingFinancing

Immunotech Biopharm Ltd Forecast EPS vs Actual EPS

-0.3-0.2-0.2-0.2-0.2-0.1-0.1-0.1Q2 24Q4 24Q2 25Q4 25Q2 26Q4 26EPS EstimateBeatMiss